Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Aug 22, 2022

Dr. Jessica Grossman is the CEO of an early stage biotech, IgGenix, the world leader in discovering and characterizing IgE antibodies which have been identified as the cause of allergies.  With an initial focus on peanut allergy, IgGenix is developing a plan to use a subcutaneous injection to block specific allergic...


Aug 22, 2022

Dr. Jessica Grossman is the CEO of an early stage biotech, IgGenix, the world leader in discovering and characterizing IgE antibodies which have been identified as the cause of allergies.  With an initial focus on peanut allergy, IgGenix is developing a plan to use a subcutaneous injection to block specific allergic...


Oct 28, 2021

Dr. Nicole Wulf is a clinical pharmacist at FDB and has recently published a study of the current evidence regarding iodine containing compounds and iodine allergy cross-reactivity.  Overall they found that there was a lack of evidence that iodine is an allergen and can cause hypersensitivity reactions particularly from...


Oct 27, 2021

Dr. Nicole Wulf is a clinical pharmacist at FDB and has recently published a study of the current evidence regarding iodine containing compounds and iodine allergy cross-reactivity.  Overall they found that there was a lack of evidence that iodine is an allergen and can cause hypersensitivity reactions particularly from...